Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne
Clinical trial NCT02575950 · COMPLETED
Trial details
- NCT number
- NCT02575950
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-04-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.